Country offers to share technology, saying results positive for the entire world
Coronavirus – latest updatesSee all our coronavirus coverage
Russia has said that its coronavirus vaccine had more than 95% efficacy according to new preliminary data, giving it a success rate comparable to vaccines being developed by Pfizer and Moderna.The country also said claimed it had greater efficacy than the Oxford/AstraZeneca vaccine because of Russia’s proprietary technology, which it offered to share with British scientists.
Sputnik V is happy to share one of its two human adenoviral vectors with @AstraZeneca to increase the efficacy of AstraZeneca vaccine. Using two different vectors for two vaccine shots will result in higher efficacy than using the same vector for two shots. #SputnikV